Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Coppo

Showing results (31-40 of 199) with videos related to

Pageof 20
Sort By:
European Journal of Internal Medicine|August 22, 2015
Rituximab in autoimmune thrombotic thrombocytopenic purpura: A success storyAntoine Froissart, Agnès Veyradier, Miguel Hié, et al.
British Journal of Haematology|April 24, 2025
How we manage immune-mediated thrombotic thrombocytopenic purpura after rituximab failure or intoleranceJulia Weisinger, Jehane Fadlallah, Bérangère Joly, et al.
Pediatric Nephrology (Berlin, Germany)|June 25, 2008
Thrombotic thrombocytopenic purpura related to severe ADAMTS13 deficiency in childrenChantal Loirat, Jean-Pierre Girma, Céline Desconclois, et al.
Haematologica|December 12, 2024
Acquired thrombotic thrombocytopenic purpura of unidentified pathophysiology in patients with severe disease: completing the landscape of thrombotic thrombocytopenic purpuraBérangère S Joly, Mathilde Leclercq, Ygal Benhamou, et al.
European Journal of Haematology|October 22, 2022
Preemptive cyclosporin A in immune-mediated thrombotic thrombocytopenic purpuraCeline Comparon, Lionel Galicier, Jean Michel Rebibou, et al.
Journal of Clinical Medicine|May 13, 2023
The Specificities of Thrombotic Thrombocytopenic Purpura at Extreme Ages: A Narrative ReviewAdrien Joseph, Bérangère S Joly, Adrien Picod, et al.
Frontiers in Pediatrics|September 5, 2024
Caplacizumab as an add-on therapy in a 7-year-old girl with exacerbated immune-mediated thrombotic thrombocytopenic purpura, a case report and literature reviewLara Chavaz, Laurent Cimasoni, Johanna A Kremer Hovinga, et al.
Clinical Case Reports|August 8, 2017
Acute pancreatitis in immunocompromised patients: beware of varicella zoster virus primo-infectionAdrien Picod, Elise Corre, Eric Maury, et al.
Hamostaseologie|February 19, 2021
Thrombotic Thrombocytopenic Purpura: When Basic Science Meets Clinical ResearchGaëlle Bécel, Sylvia Faict, Adrien Picod, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 17, 2022
Hemophagocytic Lymphohistiocytosis Associated With Cytomegalovirus Infection: 5 Cases and a Systematic Review of the LiteratureKevin Chevalier, Julien Schmidt, Paul Coppo, et al.
Pageof 20

Showing results (31-40 of 199) with videos related to

Sort By:
Pageof 20
European Journal of Internal Medicine|August 22, 2015
Rituximab in autoimmune thrombotic thrombocytopenic purpura: A success storyAntoine Froissart, Agnès Veyradier, Miguel Hié, et al.
British Journal of Haematology|April 24, 2025
How we manage immune-mediated thrombotic thrombocytopenic purpura after rituximab failure or intoleranceJulia Weisinger, Jehane Fadlallah, Bérangère Joly, et al.
Pediatric Nephrology (Berlin, Germany)|June 25, 2008
Thrombotic thrombocytopenic purpura related to severe ADAMTS13 deficiency in childrenChantal Loirat, Jean-Pierre Girma, Céline Desconclois, et al.
Haematologica|December 12, 2024
Acquired thrombotic thrombocytopenic purpura of unidentified pathophysiology in patients with severe disease: completing the landscape of thrombotic thrombocytopenic purpuraBérangère S Joly, Mathilde Leclercq, Ygal Benhamou, et al.
European Journal of Haematology|October 22, 2022
Preemptive cyclosporin A in immune-mediated thrombotic thrombocytopenic purpuraCeline Comparon, Lionel Galicier, Jean Michel Rebibou, et al.
Journal of Clinical Medicine|May 13, 2023
The Specificities of Thrombotic Thrombocytopenic Purpura at Extreme Ages: A Narrative ReviewAdrien Joseph, Bérangère S Joly, Adrien Picod, et al.
Frontiers in Pediatrics|September 5, 2024
Caplacizumab as an add-on therapy in a 7-year-old girl with exacerbated immune-mediated thrombotic thrombocytopenic purpura, a case report and literature reviewLara Chavaz, Laurent Cimasoni, Johanna A Kremer Hovinga, et al.
Clinical Case Reports|August 8, 2017
Acute pancreatitis in immunocompromised patients: beware of varicella zoster virus primo-infectionAdrien Picod, Elise Corre, Eric Maury, et al.
Hamostaseologie|February 19, 2021
Thrombotic Thrombocytopenic Purpura: When Basic Science Meets Clinical ResearchGaëlle Bécel, Sylvia Faict, Adrien Picod, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 17, 2022
Hemophagocytic Lymphohistiocytosis Associated With Cytomegalovirus Infection: 5 Cases and a Systematic Review of the LiteratureKevin Chevalier, Julien Schmidt, Paul Coppo, et al.
Pageof 20